• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[促甲状腺素受体基因的突变在毒性甲状腺腺瘤、毒性甲状腺肿结节及常染色体显性甲状腺功能亢进症发病机制中的作用]

[Mutations in the thyrotropin receptor gene in the pathogenesis of toxic thyroid adenomas, toxic goiter nodules and autosomal dominant hyperthyroidism].

作者信息

Derwahl M

机构信息

Klinik für Innere Medizin I, St.-Willehad-Hospital Wilhelmshaven.

出版信息

Z Arztl Fortbild Qualitatssich. 1999 Apr;93 Suppl 1:25-8.

PMID:10355046
Abstract

In iodine deficiency regions such as Germany, more than 50% of toxic thyroid adenomas and some toxic goiter nodules harbor activating mutations in the TSH receptor or Gs-alpha gene. These mutations cause cellular hyperfunction and hyperthyroidism but are not sufficient to generate thyroid adenomas and nodules. In the pathogenesis of these tumors, other primary and secondary molecular mechanism are operative, including overexpression of growth factors, their receptors and of signaling proteins. Expression of some of these growth factors is regulated by TSH-dependent pathways. However, iodine deficiency and its effect on thyroid growth remains the most important pathogenetic factor for these diseases. Therefore, toxic adenomas as well as the majority of nonfunctioning and eufunctioning thyroid nodules and adenomas are relatively rare in regions with high iodide intake of the population.

摘要

在德国等碘缺乏地区,超过50%的毒性甲状腺腺瘤和一些毒性甲状腺肿结节存在促甲状腺激素(TSH)受体或Gs-α基因的激活突变。这些突变导致细胞功能亢进和甲状腺功能亢进,但不足以产生甲状腺腺瘤和结节。在这些肿瘤的发病机制中,其他原发性和继发性分子机制也在起作用,包括生长因子、其受体和信号蛋白的过度表达。其中一些生长因子的表达受TSH依赖性途径调控。然而,碘缺乏及其对甲状腺生长的影响仍然是这些疾病最重要的致病因素。因此,在人群碘摄入量高的地区,毒性腺瘤以及大多数无功能和功能正常的甲状腺结节及腺瘤相对少见。

相似文献

1
[Mutations in the thyrotropin receptor gene in the pathogenesis of toxic thyroid adenomas, toxic goiter nodules and autosomal dominant hyperthyroidism].[促甲状腺素受体基因的突变在毒性甲状腺腺瘤、毒性甲状腺肿结节及常染色体显性甲状腺功能亢进症发病机制中的作用]
Z Arztl Fortbild Qualitatssich. 1999 Apr;93 Suppl 1:25-8.
2
Pathogenesis of toxic thyroid adenomas and nodules: relevance of activating mutations in the TSH-receptor and Gs-alpha gene, the possible role of iodine deficiency and secondary and TSH-independent molecular mechanisms.毒性甲状腺腺瘤和结节的发病机制:促甲状腺激素受体和Gs-α基因激活突变的相关性、碘缺乏的可能作用以及继发性和促甲状腺激素非依赖性分子机制。
Exp Clin Endocrinol Diabetes. 1998;106 Suppl 4:S6-9. doi: 10.1055/s-0029-1212048.
3
Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism.组成性激活促甲状腺激素受体突变作为毒性甲状腺腺瘤、多结节毒性甲状腺肿和常染色体显性非自身免疫性甲状腺功能亢进症的病因。
Exp Clin Endocrinol Diabetes. 1996;104 Suppl 4:129-32. doi: 10.1055/s-0029-1211720.
4
Molecular aspects of the pathogenesis of nodular goiters, thyroid nodules and adenomas.结节性甲状腺肿、甲状腺结节及腺瘤发病机制的分子学方面
Exp Clin Endocrinol Diabetes. 1996;104 Suppl 4:32-5. doi: 10.1055/s-0029-1211697.
5
[Molecular aspects in the pathogenesis of nodules and adenomas of the thyroid gland].[甲状腺结节和腺瘤发病机制的分子层面]
Schweiz Med Wochenschr. 1994 Sep 17;124(37):1613-8.
6
Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.毒性多结节性甲状腺肿中的高功能甲状腺结节与孤立性毒性腺瘤一样,都存在激活促甲状腺激素受体突变。
J Clin Endocrinol Metab. 1998 Feb;83(2):492-8. doi: 10.1210/jcem.83.2.4559.
7
Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter.刺激性促甲状腺激素受体突变存在于毒性或自主性多结节性甲状腺肿的非腺瘤性功能亢进结节中。
J Clin Endocrinol Metab. 2000 Jun;85(6):2270-4. doi: 10.1210/jcem.85.6.6634.
8
[Non-autoimmune hyperthyroidism and hyperfunctioning thyroid adenomas caused by activating mutation of the thyrotropin receptor].[促甲状腺激素受体激活突变所致非自身免疫性甲状腺功能亢进症及高功能甲状腺腺瘤]
Nihon Rinsho. 2002 Feb;60(2):291-6.
9
Gain of function TSH receptor mutations and iodine deficiency: implications in iodine prophylaxis.促甲状腺激素受体功能获得性突变与碘缺乏:碘预防的意义
J Endocrinol Invest. 2003;26(2 Suppl):2-6.
10
Pathology of the TSH receptor.促甲状腺激素受体的病理学
J Pediatr Endocrinol Metab. 1999 Apr;12 Suppl 1:295-302.